BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Melanoma Institute Australia - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Melanoma Institute Australia
X-ORIGINAL-URL:https://melanoma.org.au
X-WR-CALDESC:Events for Melanoma Institute Australia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Australia/Melbourne
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Australia/Brisbane
BEGIN:STANDARD
TZOFFSETFROM:+1000
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Australia/Sydney
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20250309T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20251102T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20260308T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20261101T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20270314T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20271107T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Australia/Perth
BEGIN:STANDARD
TZOFFSETFROM:+0800
TZOFFSETTO:+0800
TZNAME:AWST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Singapore
BEGIN:STANDARD
TZOFFSETFROM:+0800
TZOFFSETTO:+0800
TZNAME:+08
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Australia/Melbourne
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Australia/Hobart
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Tokyo
BEGIN:STANDARD
TZOFFSETFROM:+0900
TZOFFSETTO:+0900
TZNAME:JST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260516
DTEND;VALUE=DATE:20260519
DTSTAMP:20260506T083906
CREATED:20260302T035030Z
LAST-MODIFIED:20260302T035030Z
UID:10000261-1778889600-1779148799@melanoma.org.au
SUMMARY:The Australasian College of Dermatologists Annual Scientific Meeting
DESCRIPTION:The Australasian College of Dermatologists (ACD) is hosting its 58th Annual Scientific Meeting (ASM) from May 16 to 18\, 2026\, at the Melbourne Convention and Exhibition Centre in Melbourne. This event will feature a variety of sessions\, including discussions on the latest advancements in dermatology and opportunities for networking with industry leaders. The ACD aims to foster excellence in dermatology and improve patient care through innovative practices and cutting-edge treatments. \nIn 2026\, College is proud to reignite our long-standing collaboration with the Japanese Dermatological Association\, welcoming their faculty leaders to ACD ASM 58. Among our distinguished speakers from Japan are Professor Manabu Fujimoto (Osaka University)\, President of the Japanese Dermatological Association and Professor Shinichi Imafuku (Fukuoka University)\, an internationally recognised expert in infectious skin diseases. Their participation underscores the global perspective and depth of expertise that make ACD ASM 58 an unmissable event. \nLocation: Melbourne Convention & Exhibition Centre\, Melbourne\, Australia \nKey Dates: \nEarly Bird Registration Deadline: 19 March 2026\nConference Dates: 16-18 May 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/acd-asm-2026/
LOCATION:Melbourne Convention & Exhibition Centre\, 1 Convention Centre Pl\, Melbourne\, Victoria\, 3006\, Australia
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/ACD-ASM-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260522
DTEND;VALUE=DATE:20260525
DTSTAMP:20260506T083906
CREATED:20260302T034521Z
LAST-MODIFIED:20260302T034521Z
UID:10000262-1779408000-1779667199@melanoma.org.au
SUMMARY:Australasian Skin Cancer Congress
DESCRIPTION:The Australasian Skin Cancer Congress is the leading event for skin cancer professionals\, and the 2026 edition will feature a comprehensive program focused on illuminating the path ahead for skin cancer medicine in Australasia. Key themes will include advances in dermoscopy\, cutting-edge surgical tips and tricks\, improving the patient experience and much more. \nAttendees will be able to network with industry peers and witness the latest technologies in skin treatment\, with a range of opportunities available to registrants across the three-day schedule. Virtual attendance options are on offer for those not able to make the trip to Brisbane. \nLocation: The Star Brisbane\, Brisbane\, Australia \nConference Dates: 22 – 24 May 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/skin-cancer-congress/
LOCATION:The Star Brisbane\, 33 William Street\, Brisbane\, QLD\, 4000\, Australia
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/ASC-Congress-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260522T170000
DTEND;TZID=Australia/Sydney:20260522T170000
DTSTAMP:20260506T083906
CREATED:20260331T014109Z
LAST-MODIFIED:20260331T014109Z
UID:10000271-1779469200-1779469200@melanoma.org.au
SUMMARY:ACRF Annual Research Grants
DESCRIPTION:Australian Cancer Research Foundation (ACRF) awards capital grants (between $1.5 to $5 million) for technology\, equipment and infrastructure for cancer research at Australian medical research institutes\, hospitals and universities. \nGrant applications are open to research into all types of cancer with a research focus on detection\, prevention\, and/or treatment. \nSince 1984\, ACRF has awarded $209.3 million to 93 research grants in 44 Australian cancer research institutes. \nACRF promotes collaboration amongst researchers and clinicians and encourages novel and innovative cancer research projects. All applications are competitively reviewed by the ACRF Medical Research Advisory Committee (MRAC) who recommend the best projects to the ACRF Board of Trustees for funding. \nKey Dates\nApplications close: 5:00pm\, Friday 22 May 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/acrf-annual-research-grants/
CATEGORIES:Grants,Infrastructure & Equipment
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/ACRF_Annual_Grants600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260523
DTEND;VALUE=DATE:20260524
DTSTAMP:20260506T083906
CREATED:20251016T004702Z
LAST-MODIFIED:20251016T004702Z
UID:10000204-1779494400-1779580799@melanoma.org.au
SUMMARY:ASICS Runaway Noosa Marathon 2026
DESCRIPTION:The ASICS Runaway Noosa is excited to return on Saturday 23 May 2026. \nEscape to world famous Noosa for Runaway Noosa Marathon and a weekend filled with good times. With a flat\, fast and friendly multi-lap course set in the heart of Noosa township and multi distances to choose from\, it’s easy to find your happy running place right here. \nOur unique multi-lap course – starting and finishing in the heart of Noosa only steps from Hastings Street – means you’re never far from fellow runners and supporters. \nWhen you nominate MIA as your charity of choice\, funds raised support our life-saving melanoma research\, so we can reach our mission of zero deaths from melanoma. \nMake sure you set up your fundraising page\, as well as registering for the event – both can be done at the link below. \nREGISTER NOW
URL:https://melanoma.org.au/event/asics-runaway-noosa-marathon-2026/
CATEGORIES:Fundraiser,Running Events
ATTACH;FMTTYPE=image/png:https://melanoma.org.au/wp-content/uploads/2022/04/Runaway-Noosa-Marathon.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260529
DTEND;VALUE=DATE:20260601
DTSTAMP:20260506T083906
CREATED:20260129T032424Z
LAST-MODIFIED:20260129T032424Z
UID:10000239-1780012800-1780271999@melanoma.org.au
SUMMARY:IAP 50th Annual Scientific Meeting
DESCRIPTION:The 50th Annual Scientific Meeting of the Australasian Division of the International Academy of Pathology (IAP) will be held from May 29 to May 31\, 2026\, at the Brisbane Convention and Exhibition Centre in Brisbane\, Australia. This event is a significant gathering for pathologists and healthcare professionals\, offering a platform to share advancements\, research findings\, and best practices in the field of pathology. Attendees can expect informative sessions\, networking opportunities\, and the chance to engage with leading experts in the industry. \n​Key Dates \nAbstracts close: 27 February 2026 \nEarly bird registration closes: 10 April 2026 \nMeeting Venue \nBrisbane Convention and Exhibition Centre \nCnr Merivale and Glenelg Streets \nSouth Bank\, Brisbane QLD 4101 AUSTRALIA​ \n​ \nFIND OUT MORE
URL:https://melanoma.org.au/event/iap_asm_2026/
LOCATION:Brisbane Convention and Exhibition Centre\, Cnr Merivale and Glenelg Streets\, South Bank\, Brisbane\, QLD\, 4101\, Australia
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/01/IAP_50_ASM_2026-600-x-338-px-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260529
DTEND;VALUE=DATE:20260603
DTSTAMP:20260506T083906
CREATED:20251201T065545Z
LAST-MODIFIED:20260106T024359Z
UID:10000218-1780012800-1780444799@melanoma.org.au
SUMMARY:2026 ASCO Annual Meeting
DESCRIPTION:#ASCO26 is The Place to Be Inspired \nThe 2026 ASCO (American Society Of Clinical Oncology) Annual Meeting Program will feature over 200 sessions complementing Dr. Eric Small’s Presidential theme\, The Science and Practice of Translation: Improving Cancer Outcomes Worldwide. \nYour all-access pass to the most clinically relevant cancer science. #ASCO26 session highlights include: \n\nPlenary Session\, featuring the meeting’s most practice-changing and clinically relevant abstract presentations and discussions\nOpening Session\, featuring the Presidential Address and Karnofsky Award and Lecture\nASCO Voices\n24 Oral Abstract Sessions\, 24 Rapid Oral Abstract Sessions\, and 13 Clinical Science Symposia\, featuring over 450 oral abstract presentations\n15 Case-Based Panels\, featuring interactive audience polling\nJoint Sessions with AACR\, ASPO\, and ECO\nOver 2\,700 Poster presentations\, including Trials in Progress\n\nLocation: McCormick Place\, Chicago & Online \nKey Dates: \nAbstract Submitter Opens: November 5 2025\nAbstract Submission Deadline: January 27 2026\, at 11:59 PM (ET)\nLate-Breaking Abstract Submission Deadline: March 9 2026\, at 12:00 PM (Noon) (ET)\nAbstract Notification Sent to First Author: March 27 2026\nAbstract Withdrawal Deadline: April 5 2026\nAbstract Titles\, including LBAs\, Released online: April 21 2026\nRegular Abstracts Released on ASCO.org/abstracts: May 21 2026 at 5:00 PM ET \nFIND OUT MORE
URL:https://melanoma.org.au/event/2026-asco-annual-meeting/
LOCATION:McCormick Place Convention Center\, Chicago\, IL\, 60616\, United States
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/png:https://melanoma.org.au/wp-content/uploads/2025/12/2026-ASCO-1-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260529T170000
DTEND;TZID=Australia/Sydney:20260529T170000
DTSTAMP:20260506T083906
CREATED:20260331T013722Z
LAST-MODIFIED:20260401T011603Z
UID:10000273-1780074000-1780074000@melanoma.org.au
SUMMARY:Perpetual Ramaciotti Medal for Excellence in Biomedical Research
DESCRIPTION:The Ramaciotti Medal is an annual award of $50\,000. The Medal honours an individual who has made an outstanding discovery (or discoveries) in clinical or experimental biomedical research that has had an important impact on biomedical science\, clinical science\, or the way in which healthcare is delivered. \nTo be eligible for the Ramaciotti Medal\, the greater part of the nominee’s work leading to the discovery (or discoveries) must have been conducted in Australia and they must still be actively engaged in this work. \nThe applicant must be peer nominated and the final recipient is selected based on a recommendation by the Ramaciotti Foundations Scientific Advisory Committee to Perpetual. Many past winners are highly regarded individuals in the top echelon of the biomedical research industry. \nKey Dates\nApplications close: Friday 29 May 2026\, 5pm AEST\nApplicants advised of outcome: September 2026\nRecipients announced: October 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/perpetual-ramaciotti-medal-for-excellence/
CATEGORIES:Grants,Discovery
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/Ramaciotti_Medal_Perpetual-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260529T170000
DTEND;TZID=Australia/Sydney:20260529T170000
DTSTAMP:20260506T083906
CREATED:20260331T013938Z
LAST-MODIFIED:20260401T011222Z
UID:10000272-1780074000-1780074000@melanoma.org.au
SUMMARY:Perpetual Ramaciotti Health Investment Grants
DESCRIPTION:Ramaciotti Health Investment grants of up to $100\,000 are awarded to individuals in universities\, public hospitals or institutes for a contribution towards the undertaking of health or medical research with the potential path to clinical application within five years. A Health Investment grant is intended to provide enabling research support for an autonomous early career investigator who is taking\, or has recently taken\, a substantive position. \nGrants are awarded by Perpetual\, Trustee of the Foundations\, on the recommendation of a dedicated Scientific Advisory Committee. \nIn 2026 The Ramaciotti NSW Foundation will award up to six grants and The Ramaciotti Australia Foundation up to four grants. The Ramaciotti Australia Foundation supports organisations outside of NSW. \nKey Dates\nApplications close: Friday 29 May 2026\, 5pm AEST\nApplicants advised of outcome: September 2026\nRecipients announced: October 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/perpetual-ramaciotti-health-investment-grants/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/Ramaciotti-Health-Investment-Grants-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260530T170000
DTEND;TZID=Australia/Sydney:20260530T170000
DTSTAMP:20260506T083906
CREATED:20260331T013448Z
LAST-MODIFIED:20260331T013448Z
UID:10000274-1780160400-1780160400@melanoma.org.au
SUMMARY:The Viertel Charitable Foundation Clinical Investigator Awards
DESCRIPTION:Establishment grants for Clinical Investigators have been initiated by the Foundation in order to stimulate and encourage clinical research in Australia. In particular the grants are intended to assist new investigators to establish their research programs at the time of the difficult transition from doctoral and post-doctoral training posts to their first definitive clinical positions in an academic environment. Clinical Investigators are awarded a once only grant of $90\,000. \nEligible applicants will be medical graduates or graduates of other clinical disciplines who have completed both their clinical and research training which will normally be at doctoral level and are commencing their first definitive clinical position\, or have been in such a post for no more than 36 months on 1 May of the year of application. \nApplicants should be actively engaged in clinical work and pursuing health and medical research in a university clinical department\, a teaching hospital\, a clinical research unit of a research institute or in an academic general practice setting. The applications will be judged predominantly on the quality of the applicant’s track record and career achievements to date. The quality of a brief research proposal will also be taken into account. \nKey Dates\nApplications open: 6 April 2026\nApplications close: 30 May 2026 \nThe Guidelines will be available here when the round opens. \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/the-viertel-foundation-investigator-awards/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/The-Viertel-Clinical-Investigator-Awards-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260603
DTEND;VALUE=DATE:20260604
DTSTAMP:20260506T083906
CREATED:20260505T061237Z
LAST-MODIFIED:20260505T061237Z
UID:10000285-1780444800-1780531199@melanoma.org.au
SUMMARY:Westmead Research Hub EMCR Symposium
DESCRIPTION:The annual Westmead Research Hub EMCR Symposium brings together honest career journeys\, practical tips & tricks\, and high-quality oral presentations showcasing the incredible research from our EMCR community. \nHear from keynote speakers Professor Marc Wilkins and Professor Eddie Holmes who will share the real stories behind their career paths – what worked\, what didn’t\, and what they wish they’d known sooner. From navigating career transitions and building confidence to making the most of opportunities (and surviving setbacks)\, these sessions are all about practical advice you can actually use. \nAlongside the career-focused talks\, our programme features a series of short oral presentations and poster presentations highlighting innovative research from EMCRs across the research hub. \nWe will finish the day off with a panel discussion about “How to conduct impactful research” with A/Prof Emily Blyth\, Prof Hilda Pickett\, Prof Tony Weiss\, and Professor Michael Griffiths. \nWhether you’re figuring out your next step\, polishing your presentation skills\, or just keen to connect with fellow EMCRs who understand what you are going though\, this symposium promises insight\, encouragement\, and plenty of take-home tips. \nLocation: Westmead Innovation Centre\, Westmead\, NSW \nKey Date: 3 June 2026\, 8:30 am – 5 pm AEST \nRegistration Closes: 22 May 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/wrh_emcr_symposium/
LOCATION:Westmead Innovation Centre\, Hawkesbury Rd\, Sydney\, NSW\, 2145\, Australia
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/04/WRH_EMCR_2026-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260603T170000
DTEND;TZID=Australia/Sydney:20260603T170000
DTSTAMP:20260506T083906
CREATED:20260331T013308Z
LAST-MODIFIED:20260331T013308Z
UID:10000275-1780506000-1780506000@melanoma.org.au
SUMMARY:NHMRC Postgraduate Scholarships
DESCRIPTION:The National Health and Medical Research Council (NHMRC) Postgraduate Scholarships scheme funds successful applicants to attain a research based postgraduate degree – Doctor of Philosophy (PhD) or a Research Masters Degree. \n\nIt aims to support these outstanding health and medical graduates early in their career so they can be trained to conduct research that is internationally competitive and develop a capacity for original independent research within Australia. \nThe intended outcome of the Postgraduate Scholarships scheme is increased research capacity within Australia. \nPostgraduate Scholarships may be funded by\, or in conjunction with\, other organisations. These grants offer opportunities to researchers whose work is particularly relevant to the priorities and research interests of the partner organisations. \n\nKey Dates\nApplications open: 8 April 2026\nMinimum data due date: 13 May 2026\nApplications close: 3 June 2026\nProposed peer review: July/August 2026 \nThe Guidelines will be available here when the round opens. \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/nhmrc-postgrad-scholarships/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/NHMRC-Postgraduate-Scholarships-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260604T170000
DTEND;TZID=Australia/Sydney:20260604T170000
DTSTAMP:20260506T083906
CREATED:20260505T054709Z
LAST-MODIFIED:20260505T054709Z
UID:10000289-1780592400-1780592400@melanoma.org.au
SUMMARY:SNOW MEDICAL Snow Fellowship
DESCRIPTION:Snow Fellowships target emerging global research leaders that show the potential to drive\, manage and influence the next generation of health and medical innovation. The Fellowship provides these emerging leaders the independence\, funding and time to develop a bold research program\, build their research team\, and establish leadership experience. \nEach Snow Fellowship will be valued at approximately $8 million over eight years for eligible early to mid-career researchers. Fellowship funding will be available to set up and operate a research laboratory\, comprising salaries for the Snow Fellow and post doctoral researchers\, PhD student scholarship top-ups\, technical and laboratory management support\, project funds and leadership development. \nThe Snow Fellowship program supports ambitious research and high-performing teams\, and we believe that these are based on diversity\, inclusivity and gender equality. \nSnow Fellowship \nBiomedical research\nUp to $1M per year\n8 years of funding (review at year 4/5)\nMentorship\, leadership and management training support \nKey Dates \nExpression of Interest closes: 4 June 2026\nFull Application opens (via invitation): 1st week of August 2026\nFull Application closes: 1 October 2026\nInterview: early February 2027 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/snow_medical/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/Snow-Fellowship-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260607
DTEND;VALUE=DATE:20260608
DTSTAMP:20260506T083906
CREATED:20251016T010239Z
LAST-MODIFIED:20251016T010239Z
UID:10000205-1780790400-1780876799@melanoma.org.au
SUMMARY:Rosebud Running Festival 2026
DESCRIPTION:The Rosebud Running Festival course will cover sections along the foreshore trails (Bay trial) with runners being able to enjoy running through some stunning landscapes with Port Phillip Bay as the backdrop. The course will take competitors from the Start/Finish line at Rosebud to McCrae and back to Rosebud for the 5km and 10km events. The Marathon (2 Laps) + Half Marathon competitors will continue past the start line at Rosebud and head towards Capel Sound with the turnaround just before the Rye Pier and finish at Rosebud. The weekend features a variety of running & walking events to suit all ages and fitness levels. All finishers receive a finishers medal. \nWhen you nominate MIA as your charity of choice\, funds raised support our life-saving melanoma research\, so we can reach our mission of zero deaths from melanoma. \nMake sure you set up your fundraising page\, as well as registering for the event – both can be done at the link below. \nREGISTER NOW
URL:https://melanoma.org.au/event/rosebud-running-festival-2026/
CATEGORIES:Fundraiser,Running Events
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2025/10/Rosebud-Running-Festival-.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260607
DTEND;VALUE=DATE:20260608
DTSTAMP:20260506T083906
CREATED:20251016T025834Z
LAST-MODIFIED:20251027T235104Z
UID:10000206-1780790400-1780876799@melanoma.org.au
SUMMARY:Brisbane Marathon Festival 2026
DESCRIPTION:The Brisbane Marathon Festival is an annual running event featuring a marathon\, half marathon\, 10 km\, 5 km\, and 2 km race\, attracting thousands of participants. The feeling of crossing that finish line and achieving your goal is like no other\, so take that first step and sign up now! \nWhen you nominate MIA as your charity of choice\, funds raised support our life-saving melanoma research\, so we can reach our mission of zero deaths from melanoma. \nMake sure you set up your fundraising page\, as well as registering for the event – both can be done at the link below. \nREGISTER NOW
URL:https://melanoma.org.au/event/brisbane-marathon-festival-2026/
CATEGORIES:Fundraiser,Running Events
ATTACH;FMTTYPE=image/png:https://melanoma.org.au/wp-content/uploads/2024/10/Brisbane-Marathon-Festival-2025-1200x675-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260617
DTEND;VALUE=DATE:20260620
DTSTAMP:20260506T083906
CREATED:20260331T011919Z
LAST-MODIFIED:20260331T011919Z
UID:10000280-1781654400-1781913599@melanoma.org.au
SUMMARY:CNSA Annual Congress
DESCRIPTION:The Cancer Nurses Society of Australia (CNSA) Annual Congress is the premier national event for cancer nurses\, researchers\, educators\, and leaders in cancer care. Each year\, Congress brings together professionals from across Australia to connect\, share\, and advance cancer nursing practice. \nOver three days\, delegates experience keynote presentations\, interactive workshops\, concurrent sessions\, poster displays\, and networking events designed to inform\, inspire\, and empower. Congress provides a platform to exchange ideas\, explore evidence-based innovations\, and shape the future of cancer care through nursing leadership and advocacy. \nIn 2026\, under the theme Elevate Cancer Nursing: Innovate. Integrate. Educate. Advocate.\, we’ll highlight how nurses are driving change — translating evidence into practice\, leading multidisciplinary collaboration\, and championing equity in cancer care. \nLocation: Perth Convention and Exhibition Centre\, Australia \nKey Dates: 17 – 19 June 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/cnsa-annual-congress/
LOCATION:Perth Convention and Exhibition Centre\, 21 Mounts Bay Rd\, Perth\, WA\, 6000\, Australia
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/CNSA-Congress600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260618
DTEND;VALUE=DATE:20260621
DTSTAMP:20260506T083906
CREATED:20260302T043440Z
LAST-MODIFIED:20260302T043440Z
UID:10000259-1781740800-1781999999@melanoma.org.au
SUMMARY:2026 New Zealand Skin Cancer Summit
DESCRIPTION:The Summit Organising Committee invites you to join the 2026 New Zealand Skin Cancer Summit. This year marks a new chapter — the first Summit under the new name\, Skin Cancer New Zealand\, and the first to address all types of skin cancer\, not just melanoma. \nOur 2026 theme\, “Equity in action: Bridging gaps for skin cancer”\, reflects our commitment to ensuring prevention\, early detection\, treatment\, and support are accessible and equitable for everyone. The programme will feature engaging keynote presentations\, interactive panels and skills-based workshops showcasing innovative research\, practical strategies\, and collaborative approaches. \nBringing together clinicians\, researchers\, educators\, policymakers\, and advocates from across New Zealand and beyond\, the Summit offers a unique opportunity to share knowledge\, strengthen networks\, and set priorities for skin cancer management that will help to reduce the burden of disease and improve outcomes for those affected. \nOptional pre-Summit workshops | 18 June 2026 \n9.00 am – 12.30 pm: Skin Surgery Masterclass \n1.30 pm – 4.30 pm: Advanced Dermoscopy Masterclass \nThese workshops can be booked individually or together with the Summit. Summit registration is not required to sign up for one or both workshops. \nNew Zealand Skin Cancer Summit | 19 – 20 June 2026 \nWith the theme of bridging gaps in skin cancer\, the Summit will aim to shape a coordinated and equitable future for skin cancer care\, foster collaboration\, and share the latest advancements in prevention\, diagnosis\, treatment and research. A dynamic programme packed with internationally recognised experts and sessions on prevention\, diagnosis\, clinical management\, and research\, makes this an event not to be missed. \nLocation: InterContinental Wellington\, Wellington\, NZ \nKey Dates: \nEarly bird registration closes: 31 March 2026\nAbstract Submission deadline: 27 March 2026\nAbstract Outcomes: 17 April 2026\nE-poster Submission deadline: 23 May 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/2026-nz-skin-cancer-summit/
LOCATION:InterContinental Wellington\, 2 Grey Street\, Wellington\, 6011\, New Zealand
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/02/2026-NZ-Skin-Cancer-Summit600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260621
DTEND;VALUE=DATE:20260622
DTSTAMP:20260506T083906
CREATED:20251016T031613Z
LAST-MODIFIED:20251016T031613Z
UID:10000207-1782000000-1782086399@melanoma.org.au
SUMMARY:Hervey Bay Half Marathon Festival 2026
DESCRIPTION:The Hervey Bay Half Marathon Festival offers runners a truly unique coastal experience\, set against the stunning backdrop of Queensland’s Fraser Coast. With sweeping ocean views\, tranquil beaches\, and an inviting esplanade lined with palms and cafés\, participants will be immersed in the laid-back charm and natural beauty of this coastal paradise. \nWhether you’re chasing a personal best or simply soaking up the scenery\, the course makes the perfect setting for all types of runners—from seasoned athletes to first-timers. \nWith a variety of distances on offer — Half Marathon – 21.1km | 10km | 5km run & 5km walk | 2km Fun Run & Walk — there’s something for everyone to experience the excitement of crossing the finish line along Hervey Bay’s iconic foreshore. \nWhen you nominate MIA as your charity of choice\, funds raised support our life-saving melanoma research\, so we can reach our mission of zero deaths from melanoma. \nMake sure you set up your fundraising page\, as well as registering for the event – both can be done at the link below. \nREGISTER NOW
URL:https://melanoma.org.au/event/hervey-bay-half-marathon-festival-2026/
CATEGORIES:Fundraiser,Running Events
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2025/10/Hervey-Bay-Marathon-Festival.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260625
DTEND;VALUE=DATE:20260628
DTSTAMP:20260506T083906
CREATED:20260505T061717Z
LAST-MODIFIED:20260505T061717Z
UID:10000286-1782345600-1782604799@melanoma.org.au
SUMMARY:ASCO Breakthrough
DESCRIPTION:ASCO Breakthrough is an annual Asia-Pacific oncology meeting offering novel research and expert\, multidisciplinary perspectives on the newest scientific findings\, clinical and technology advances\, and treatment approaches that are rapidly changing cancer care. Take part in insightful sessions\, case discussions\, and abstract presentations\, and join a community of like-minded professionals to contribute\, together\, toward conquering cancer. \nWhy Attend ASCO Breakthrough? \n\nAccess Global Science with Regional Perspectives\nConnect with the Global ASCO Community in Asia\nGain Insight to Enhance Your Clinical Practice\n\nProgram Overview \nSessions will cover a range of topics\, including: \n\nConfronting the Global Surge of Early-Onset Cancers\nA Discussion on What It Will Take to Make Clinical Artificial Intelligence a Reality at the Bedside\nAntibody-Drug Conjugates\nNew Immunotherapy Combination Strategies\nMinimal Residual Disease in 2026 and What Is On The Horizon\nAdvancing Equitable Oncology in the Asia-Pacific Region – Bridging Gaps With Common Sense\nCase-Based Sessions focused on Liver Cancer\, Cervical Cancer\, and Oral Cavity Cancers\n\nThe Program will also include scientific update sessions\, the presentations of new and novel scientific advances\, and opportunities for attendees to network and connect with each other to build meaningful partnerships. \nLocation: Raffles City Convention Centre\, Singapore \nKey Dates: \nConference dates: 25 – 27 June\, 2026 \nEarly registration deadline: 20 May\, 2026 at 11:59 PM (ET) \nFIND OUT MORE
URL:https://melanoma.org.au/event/asco_breakthrough/
LOCATION:Raffles City Convention Centre\, 80 Bras Basah Road\, Singapore\, 189560\, Singapore
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/04/ASCO-Breakthrough-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260707T170000
DTEND;TZID=Australia/Sydney:20260707T170000
DTSTAMP:20260506T083906
CREATED:20260505T055547Z
LAST-MODIFIED:20260505T055547Z
UID:10000290-1783443600-1783443600@melanoma.org.au
SUMMARY:RACP Research Awards and Career Grants
DESCRIPTION:Through the RACP Foundation\, we’re able to offer financial support to Fellows and trainees pursuing careers in medical research. Over 50 different fellowships\, scholarships and grants are available annually\, totalling over $2.5 million in funding. \nCareer Development Fellowships are intended for mid-career researchers who completed their research higher degree over 7 years ago and/or researchers who are not eligible for either Research Entry Scholarship or Research Establishment Fellowships. \nResearch Establishment Fellowships are available to Fellows and Advanced Trainees who want to establish themselves in a research career. \nResearch Entry Scholarships provide stipend support only and are to assist Fellows and Advanced Trainees who are: \n\nat the start of their research careers and about to enrol in a Masters\, PhD or equivalent research higher degree\nin the 1st or 2nd full-time equivalent year of their research degree.\n\n\nKey Dates\nApplications close: 30 June 2026\nApplications close (Research Entry Scholarships): 7 July 2026\nOutcomes advised: December 2026 \nSEE WEBSITE
URL:https://melanoma.org.au/event/racp-awards-grants/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/RACP-Awards-and-Grants-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260714
DTEND;VALUE=DATE:20260729
DTSTAMP:20260506T083906
CREATED:20260401T234731Z
LAST-MODIFIED:20260407T235036Z
UID:10000282-1783987200-1785283199@melanoma.org.au
SUMMARY:MPA-MIA Community Webinar Series 2026
DESCRIPTION:Join us for an informative series of three live webinars for patients with melanoma and their carers. \nHosted by Melanoma Patients Australia (MPA) and Melanoma Institute Australia (MIA)\, each week our free webinar will provide you with a rare opportunity to hear from medical experts and community members as they focus on a different topic of interest each week. The webinar will conclude with a Q&A panel discussion. \nThe webinars are held every Tuesday evening for three weeks. Please click on the registration link below for each webinar that you’d like to attend. \nNote that the webinars are held from 7pm to 8pm AEST.\nCost: Free \nWebinar One: ‘Your melanoma nurse: What they do and how they help’ \nWhen: Tuesday 14 July | 7 – 8pm AEST \nSpeakers: \n\nRebecca Johnson – National Melanoma Nurses Program Manager\nPeta Holly – Specialist Melanoma Telehealth Nurse\nA community member\n\nREGISTERWebinar Two: ‘Understanding endocrine side effects of immunotherapy’\nWhen: Tuesday 21 July | 7 – 8pm AEST \nSpeakers: \n\nDr Stephanie Zunder – Medical Oncologist\nDr Annabel Hayes – Endocrinologist\nAled Gaynor – Medical Oncology Clinical Nurse Consultant\nA community member\n\nREGISTERWebinar Three: ‘Understanding sentinel lymph node biopsies: Helping you decide’ \nWhen: Tuesday 21 July | 7 – 8pm AEST \nSpeakers: \n\nA/Prof Alexander van Akkooi – Surgical Oncologist\nShahn Coburn – Surgical Clinical Nurse Consultant\nA community member\n\nREGISTER
URL:https://melanoma.org.au/event/mpa-mia-community-webinar-series-2026/
CATEGORIES:Education,Patient Education
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/04/MIAE0367-MIA-_-MPA_WEB-BANNER_1200x675-series.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260714T170000
DTEND;TZID=Australia/Sydney:20260714T170000
DTSTAMP:20260506T083906
CREATED:20260505T055930Z
LAST-MODIFIED:20260505T055930Z
UID:10000291-1784048400-1784048400@melanoma.org.au
SUMMARY:MRFF National Critical Research Infrastructure
DESCRIPTION:The 2026 National Critical Research Infrastructure initiative invests in research infrastructure to ensure Australian researchers find innovative solutions to complex health problems in areas of unmet medical need. This grant opportunity has four streams. \nStream 1 – Innovation enablers\nAddress an area of unmet medical need by promoting the development and implementation of new research infrastructure by supporting development and/or expansion of research enablers such as biobanks\, tissue repositories\, novel platforms\, and secure health data environments to create valuable research resources. \nStream 2 – Digitisation of health care\nTranslate or implement innovative artificial intelligence technologies into health applications that: \n\nbenefit multiple health disciplines/areas\ninvolve consumers in the research journey to ensure the research is applicable to the needs of the Australian community; and\nincrease artificial intelligence workforce capacity and capability\, particularly in relation to health\, through cross-sector and interdisciplinary collaboration.\n\nStream 3 – Co-investment partnerships\nUtilise co-investment (cash only) with the research sector\, state and/or territory governments\, and industry\, in significant critical research infrastructure (e.g. facilities\, personnel and equipment): \n\nto support development of research capacity\, capability and/or effectiveness in an area of unmet medical need\, or\nto enable Australian research using new platforms\, systems and services in an area of unmet medical need.\n\nStream 4 – mRNA technology enablers\nLeverage and enhance emerging mRNA technologies\, platforms\, and/or equipment to accelerate development of mRNA-based vaccines and therapeutics in an area of unmet medical need. \nGrants to fund research infrastructure projects\, up to $3 million in Streams 1\, 2 and 4\, and up to $7 million in Stream 3. \nAn application may only be submitted to one of the above four streams. Applicants must specify the stream to which they are applying in their application. \n\n\n\nKey Dates\nApplications close: 14 July 2026\nIndicative funding status: Funding anticipated to be awarded from December 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-research-infrastructure/
CATEGORIES:Grants,Infrastructure & Equipment
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/MRFF_Critical-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260722T170000
DTEND;TZID=Australia/Sydney:20260722T170000
DTSTAMP:20260506T083906
CREATED:20260505T060230Z
LAST-MODIFIED:20260505T060230Z
UID:10000292-1784739600-1784739600@melanoma.org.au
SUMMARY:MRFF BioMedTech Incubator
DESCRIPTION:The MRFF 2026 BioMedTech Incubator Program provides grants of financial assistance to support medical research and medical innovation projects through the establishment of BioMedTech Incubators. \nThis grant is for an eligible organisation who can establish a working incubator\, to partner with Australian small and medium enterprises (SMEs) to progress new and innovative medical research projects through the early stages of development. \nThe 2026 BioMedTech Grant Opportunity is part of the Medical Research Future Fund under the Medical Research Commercialisation Initiative. \nThis opportunity looks to fund suitable organisations to identify\, select and support Australian SMEs undertaking early-stage medical research and medical innovation projects that have commercial potential. \nThe intended outcome of the research funded by this grant opportunity is to improve the health and wellbeing of Australians by increasing the number of SMEs developing novel biomarkers\, diagnostics\, therapeutics\, assistive devices and/or digital technologies that have progressed through the early stages of research and development to the point where they are ‘de-risked’ and attractive to private investment for commercialisation. \nApplicants may propose to support development of innovations in their area/s of strength (i.e. applicants are not required to propose a program that covers the breadth of the biomedtech sector). \nGrants of up to $33 million to establish BioMedTech Incubators. \n\nKey Dates\nApplications close: 22 July 2026\nIndicative funding status: Funding anticipated to be awarded from December 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-incubator/
CATEGORIES:Grants,Industry
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/MRFF_Incubator-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260723
DTEND;VALUE=DATE:20260726
DTSTAMP:20260506T083906
CREATED:20260331T012303Z
LAST-MODIFIED:20260331T012303Z
UID:10000278-1784764800-1785023999@melanoma.org.au
SUMMARY:ASDR Annual Scientific Meeting
DESCRIPTION:The Australasian Society for Dermatology Research (ASDR) is pleased to invite you to the ASDR 2026 Annual Scientific Meeting\, to be held in person from 23–25 July 2026 at the Westmead Innovation Centre\, Sydney\, Australia. The meeting will deliver a comprehensive scientific program featuring leading national and international experts\, highlighting recent progress and emerging directions in dermatology research. Key areas to be explored include: \n\nKeratinocyte and Squamous Cell Carcinomas\nMelanocyte/ Keratinocyte biology\nMicroenvironment\nFundamental Skin Research\nSkin immunology and immune disorders\nAutoimmune Disorders\nWound Healing and Stem Cells\nMelanoma and Pigmentation Disorders\nSkin Translational Research\n\nWe look forward to bringing together researchers\, clinicians\, and industry leaders to foster collaboration and discussion on the most innovative topics in dermatology research. \nLocation: Westmead Innovation Centre\, Sydney\, Australia \nKey Dates: \nAbstract Submission Deadline: 19 April 2026\nAbstract Outcomes: 15 May 2026\nEarly Bird Registration Deadline: 30 June 2026 at 23:59 AEST\nRegistration Deadline: 16 July 2026 at 23:59 AEST \nFIND OUT MORE
URL:https://melanoma.org.au/event/asdr-annual-meeting/
LOCATION:Westmead Innovation Centre\, Hawkesbury Rd\, Sydney\, NSW\, 2145\, Australia
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/ASDR-ASM-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260724
DTEND;VALUE=DATE:20260726
DTSTAMP:20260506T083906
CREATED:20260129T022216Z
LAST-MODIFIED:20260129T023350Z
UID:10000238-1784851200-1785023999@melanoma.org.au
SUMMARY:Plastic Surgery Congress 2026
DESCRIPTION:Australian Society of Plastic Surgeons welcomes you to the 2026 Plastic Surgery Congress (PSC)\, where the future of plastic\, reconstructive\, and aesthetic surgery takes centre stage. \n​Taking place at the Sofitel Brisbane Central\, PSC 2026 promises a dynamic program packed with cutting-edge content\, world-class presentations\, and the latest global best practices. With two full days of medical education\, hands-on workshops\, and lively social events\, the Congress is designed to spark collaboration and professional growth. \n​In 2026\, delegates can expect an exceptional line-up of international and local faculty\, carefully curated to provide a truly bespoke educational experience. We have introduced a refreshed academic focus\, featuring topics not previously explored in depth at past congresses. These include burns\, peroneal reconstruction\, hands and brachial plexus surgery\, and aesthetics. And of course\, no congress held in Brisbane would be complete without a dedicated emphasis on skin cancer. \n​Expect an exceptional line-up of international and local experts who will showcase ground-breaking techniques and transformative ideas shaping the field today. \n​Key Dates \nAbstracts close: 9 February 2026 \nEarly bird registration closes: 22 April 2026 \nCongress Venue \nSofitel Brisbane Central \n249 Turbot Street Brisbane QLD 4000 AUSTRALIA​ \n​ \nFIND OUT MORE
URL:https://melanoma.org.au/event/psc_2026/
LOCATION:Sofitel Brisbane Central\, 249 Turbot Street\, Brisbane\, QLD\, 4000\, Australia
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/01/PSC_2026-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260805
DTEND;VALUE=DATE:20260808
DTSTAMP:20260506T083906
CREATED:20260331T012114Z
LAST-MODIFIED:20260331T012114Z
UID:10000279-1785888000-1786147199@melanoma.org.au
SUMMARY:MOGA Annual Scientific Meeting
DESCRIPTION:The 2026 MOGA Annual Scientific Meeting (ASM) will bring together Australian medical oncologists to reflect on a timely theme: \nReimagining Cancer Care: Is Less Doing More? \nIn recent years\, oncology has found itself at a fascinating crossroads. With ever-deepening insights into tumour biology\, immunotherapy\, molecular profiling\, and patient-centred care\, we are beginning to ask a powerful and\, at times\, uncomfortable question: Are we sometimes doing too much? \nWe are now confronting the possibility that treatment de-escalation is not just a compromise\, but potentially a pathway to more humane\, precise\, and effective care. This conversation extends well beyond protocols and guidelines. It challenges us to think deeply about patient autonomy\, shared decision-making\, and what quality of life truly means in the era of personalised medicine. \nThis ASM will bridge disciplines and perspectives—from surgical oncology to medical and radiation oncology\, to palliative care and psychosocial support. We will consider not only clinical evidence\, but also the ethical\, logistical\, and emotional dimensions of doing less. We will look at emerging biomarkers and novel drug targets that allow us to fine-tune therapy like never before. Exploring what it means to personalise care in the truest sense—not just through science\, but through listening. \nLocation: RACV Royal Pines\, Gold Coast\, Australia \nKey Dates: \nEarly Bird Registrations Close: 14 June 2026\nAbstract Submissions Close: 14 June 2026\nAbstract Selection Advice: 3 July 2026\nAbstract Acceptance by Presenter: 10 July 2026\nTravel Award Applications Open: 3 July 2026\nTravel Award Applications Close: 10 July 2026\nTravel Award Recipient Notification: 17 July 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/moga-annual-scientific-meeting/
LOCATION:RACV Royal Pines Resort\, Ross Street\, Gold Coast\, Queensland\, 4217\, Australia
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/MOGA-Asm-600-x-338-px-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260819T170000
DTEND;TZID=Australia/Sydney:20260819T170000
DTSTAMP:20260506T083906
CREATED:20260505T060732Z
LAST-MODIFIED:20260505T060732Z
UID:10000293-1787158800-1787158800@melanoma.org.au
SUMMARY:MRFF Genomics Health Futures
DESCRIPTION:The objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that: \nStream 1 (TCR): develop genomic tools and technologies to identify genetic predisposition to cancer and improve screening and targeted intervention. Focus on increased access to genomic testing and on liquid biopsy. \nStream 2 (TCR): conduct scalable research to enhance novel gene discoveries\, increase diagnostic rates and enable disease modelling to support development of targeted therapies or prevention strategies. \nStream 3 (Incubator): develop novel methods for using polygenic risk scores to identify subgroups of the population at high risk of common and complex diseases (cardiovascular disease\, diabetes and other common and/or complex diseases). \nStream 4 (Incubator): develop novel methods for improving accuracy and usefulness of polygenic risk scores to stratify people with common cancers for surveillance and treatment (breast cancer\, colorectal cancer\, prostate cancer and other common cancers) \nStream 5 (TCR): undertake research to enhance or streamline uptake of clinical genomics into practice. \nStream 6 (Accelerator): develop and maintain infrastructure to support research collaboration by enabling data sharing\, portability\, longevity and connectivity of analysis across Australia. Research conducted should address emerging ethical\, legal and social issues associated with the governance of clinical and genomic datasets with particular focus on the application of advanced analytics (e.g. AI) to enhance the diagnostic utility of genomics. \nApplicants must propose research that addresses these objectives and those of the Genomics Health Futures Mission as outlined in the Roadmap and Implementation Plan. \nKey Dates \n\nMinimum data due date: 22 July 2026\nApplications close: 19 August 2026\nIndicative funding status: Funding anticipated to be awarded from June 2027 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-genomics-health-futures/
CATEGORIES:Grants,Industry
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/MRFF-Genomics-Health-Futures600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260830
DTEND;VALUE=DATE:20260831
DTSTAMP:20260506T083906
CREATED:20251016T032249Z
LAST-MODIFIED:20251024T040143Z
UID:10000208-1788048000-1788134399@melanoma.org.au
SUMMARY:2026 TCS Sydney Marathon presented by ASICS
DESCRIPTION:Whether you’re chasing your debut or your next star\, the TCS Sydney Marathon presented by ASICS is your moment to shine. \nSydney is the bucket-list race that redefines what’s possible\, so come experience the place where the world comes to finish. \nWhen you nominate MIA as your charity of choice\, funds raised support our life-saving melanoma research\, so we can reach our mission of zero deaths from melanoma. \nMake sure you set up your fundraising page\, as well as registering for the event – both can be done at the link below. \nREGISTER NOW
URL:https://melanoma.org.au/event/2026-tcs-sydney-marathon-presented-by-asics/
CATEGORIES:Fundraiser,Running Events
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2025/06/TCS-Sydney-Marathon-2025.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260912
DTEND;VALUE=DATE:20260917
DTSTAMP:20260506T083906
CREATED:20260331T012815Z
LAST-MODIFIED:20260331T012815Z
UID:10000256-1789171200-1789603199@melanoma.org.au
SUMMARY:European Congress of Pathology
DESCRIPTION:The European Society of Pathology (ESP) and the Swedish Society of Pathology are delighted to invite you to the 38th European Congress of Pathology (ECP 2026)\, to be held at Stockholmsmässan\, from 12 –16 September 2026\, in the heart of Sweden’s capital. \nECP 2026 will bring together more than 5\,000 participants from all over the world—pathologists\, clinicians\, researchers\, molecular biologists\, bioinformaticians\, medical scientists\, and industry partners. The meeting will provide an ideal opportunity for professional development\, networking\, to exchange insights\, and will demonstrate the commitment of the ESP to contributing to Pathology progress in the near future. \nThe motto of the congress – “Innovation Driving Excellence in Pathology” –acknowledges the significant improvement that pathology innovation has brought and continues to bring to diagnostics\, assessment of prognosis and therapy response prediction and clinical practice. The excellent programme prepared by the ESP working groups\, ESP-affiliated societies\, education and trainee committees\, and other collaborating societies will include keynote lectures\, slide seminars\, symposia\, and interactive workshops\, from internationally renowned speakers and leaders in their fields. There will be a special focus on digital pathology\, AI integration\, and emerging technologies that are transforming our field. \nLocation: Stockholmsmässan\, Stockholm\, Sweden \nKey Dates: \nAbstract submission deadline: 8 April 2026\nAbstract notifications: early June 2026\nRegistration and payment deadline for authors of accepted abstracts: 25 June 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/european-congress-of-pathology/
LOCATION:Stockholmsmässan\, Mässvägen 1\, Älvsjö\, 12530\, Sweden
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/ECP-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260916
DTEND;VALUE=DATE:20260919
DTSTAMP:20260506T083906
CREATED:20260505T062122Z
LAST-MODIFIED:20260505T062122Z
UID:10000287-1789516800-1789775999@melanoma.org.au
SUMMARY:ABNA Annual Conference
DESCRIPTION:ABNA’s Annual Conference “From Collection to Discovery: Enabling Research\, Accelerating Impact” will be held in Hobart\, 16-18 September 2026. \nThe star event in the annual ABNA calendar\, this meeting provides an opportunity to connect with biobankers and biospecimen scientists from around the world to discuss shared strategies to shape the future of biobanking. The 2026 program will once again foster professional growth and encourage a commitment to excellence through expert talks exploring novel approaches to traditional biospecimen science as well as and cutting-edge biobanking technology. \nEnjoy workshops\, special interest group meetings\, rapid fire presentations\, poster displays\, and elevator pitch presentations as well as a range of networking events including biobanker speed networking\, a site visit and gala dinner to facilitate collaborations with researchers\, policymakers\, corporate sponsors and industry leaders to drive innovation and partnership. \nDon’t miss this chance to engage with the Australasian Biobanking community in the stunning city of Hobart – home to a thriving research and education sector. See you there! \nLocation: Crown Plaza Hobart\, Tasmania \nKey Dates: \nAbstract submission deadline: 14 August 2026\nAbstract notifications: late August/early September 2026\nEarly bird registration deadline: 31 July 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/abna_conference/
LOCATION:Crowne Plaza Hobart\, 110 Liverpool Street\, Hobart\, Tasmania\, 7000\, Australia
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/04/ABNA_2026-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261008
DTEND;VALUE=DATE:20261014
DTSTAMP:20260506T083906
CREATED:20260331T012601Z
LAST-MODIFIED:20260331T012601Z
UID:10000277-1791417600-1791935999@melanoma.org.au
SUMMARY:IAP Congress
DESCRIPTION:It is with great pleasure that we welcome you to the 2026 XXXVI Congress of the International Academy of Pathology in Fukuoka\, bringing together the most enthusiastic and dedicated scholars in the field of pathology. Our goal is to create a unique platform where the latest advancements\, challenges\, and debates in diagnostic and molecular pathology are shared and discussed. \nThis biennial international congress on pathology will be held jointly with the 72nd Autumn Annual Meeting of the Japanese Society of Pathology\, which is held annually in Japan. \nAs the theme of this year’s congress is “Vision for the Future”\, we would like to hold a joint session in the sense of a new challenge that is not bound by the conventional format for the continued development of IAP. Key topics in molecular pathology including spatial transcriptome analysis and artificial intelligence will be explored across various subspecialties\, reflecting the evolving landscape of our field. We will also provide the programs on basic issues in pathology such as the educational system and infectious diseases. \nLocation: Fukuoka International Congress Center\, Fukuoka Sunpalace\, Fukuoka\, Japan \nKey Dates: \nAbstract Submission Deadline: Friday 10 April 2026\, 17:00 (JST)\nYoung Pathologist Award Application & Abstract Submission: Friday 10 April 2026\, 17:00 (JST)\nIAP Bursary Abstract Submission: Friday 10 April 2026\, 17:00 (JST)\nIAP Bursary Application Deadline: Thursday 30 April 2026\nNotification of Acceptance: June 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/iap-congress/
LOCATION:Fukuoka International Congress Center\, 2-1 Sekijōmachi\, Fukuoka\, 8120032\, Japan
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/IAP-2026-600-x-338-px.jpg
END:VEVENT
END:VCALENDAR